Main Menu
 
  RCPN Publications-2006
    1- Mirmohseni A., Rostamizadeh K., (2006), Quartz crystal nanobalance in conjunction with principal component analysis for identification of volatile organic compounds,Sensors,6:324-34.
    2- Davaran S., Rashidi M.R., Javadi M., Hamishe kar H., (2006), Preparation and in- vitro studies of 17- β- estradiol and levonorgestrel transdermal patches using novel transdermal permeation enhancers, J Pharm Sci, Autumn: 25- 32.
    3- Barar J., Omidi Y., (2006), Microarray analysis of cationic nanoliposomes genocompatibility in human alveolar epithelial cells. J Pharm Sci, Autumn: 13-23
    4- Barar J., Maleki A.,Omidi Y., (2006), Modulation of cellular transport characteristics of the human lung alveolar epithelia ,Iranian J. Pharm. Res., 3:163-171.
    5- Hamzeiy H., Eghbal M.A.(2006), An Alkaline Phosphatse Reporter Gene Assay for Induction of CYP3A4 in vitro, Iranain J Pharm Res, 4:269-274
    6- Yari Khosroshahi A., Habibi Khaniani B., Naghdibadi H.A., (2006), Review on taxol as the most important anticancer natural drug , J.Medicinal Plants, spring:18.
    7- Davaran S., Rashidi M.R., Pourabbas B., Dadashzadeh M., Moti Hagshenas.,(2006), Adriamycin release from poly (lactide-co-glycolide)-polyethylene glycol nanoparticles: synthesis and in vitro characterization Int J Nanomedicine.,1(4):535-539.
    8- Hamzeiy H., Dastmalchi S.,(2006), Linkage analysis of three heterozygous mutations found in human CYP3A4 gene separated by long distances, J Pharm Sci, winter:63-64.
    9- Yari Khosroushahi A., Valizadeh M., Ghasempour M., Khosrowshahli M., Naghdibadi H., Dadpour M.R., Omidi Y.,(2006), Improved taxol production by combination of inducing factors in suspension cell culture of Taxus baccata, J Cell Biol Int, 3:262-69.
    10- Shokri J., Azarmi Sh., Saboury A., Shokri M.H.,(2006), Enhancement of oxazepam dissolution rate using oxazepam – surfactant solid dispersions, (J Pharmaceutical Sciences, winter:34-45
    11-  Azarmi Sh., Huang Y., Chen H., McQuarrie S., Abrams D., Roa W., H.Finlay W., G.Miller G., LÖbenberg R.,(2006), Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells, J pharmaceut Sci, 9(1):124-132.
    12- Barzegar-Jalali M., Mohajjel Nayebi A., Valizdeh H., Hanaee J., Barzegar A., Adibkia Kh.,Anoush M., Sistanizad M.,(2006),Evaluation of in vitro-in vivo correlation and anticonvulsive effect of carbamazepine after cogrinding with microcrystalline cellulose, J pharmaceut Sci, 9(1): 307-316
    13- Azarmi Sh., Tao X., Chen H., Wang Z., H.Finlay W., LÖbenberg R., Roa W.,(2006), Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles, Int. J. Pharm , 319:155-161.
    14- Shokri J., Hanaee J., Barzegar-Jalali M., Changizi R., Rahbar M., Nokhodchi A.,(2006), Improvement of the dissolution rate of indomethacin by a cogrinding technique using polyethylene glycols of various molecular weights, J.DRUG DEL.SCI.TECH, 16(3) :203-209.
    15-  Lotfipour F., ZarrintanM.H., Sherbafi J., Basak A.,(2006), Bioengineered peptides based on α1-PDX structure as inhibitors of furin: Design, synthesis and comparative efficacy,Iranian J. Pharm. Sciences, winter; 2(1):119-13.
    16-  Nazemieh H., Shokri J., Kargar M., Ahmad-Nasrolahi S., Azarmi Sh., Modarresi M.,(2005), Study on sunscreen effects of Artemia urmiana and Artemia salina total extracts and their fractions, J.pharmaceutical Sciences, autumn; 81-88.
    17-  Omidi Y., Barar J., Barzegar-Jalali M., ZarrintanM.H., (2005), Characterization of immortalized ECV304 cells cocultured with astrocytes as a cell-based blood brain barrier model for in vitro cellular biopharmaceutics studies, J. Pharmaceutical Sciences, Spring; 53-66.
    18- Shokri J., Hanaee J., Barzegar-Jalali M., Nasezadeh M.,(2005), The effects of surfactants on dissolution rate of lorazepam from solid dispersion systems, J. Pharmaceutical Sciences, summer; 53-64.
Posted
Edited